Prucalopride

Prucalopride is a selective serotonin reuptake inhibitor (SSRI) and serotonin 5-HT1A receptor partial agonist that is used to treat irritable bowel syndrome with constipation (IBS-C). It was approved by the U.S. Food and Drug Administration (FDA) in 2013. Prucalopride works by increasing the amount of serotonin in the gut, which helps to relax the muscles in the intestines and promote bowel movements. It is available in tablet form and is typically taken once daily.

Prucalopride is generally well-tolerated, but like all medications, it can cause side effects. Common side effects include nausea, diarrhea, and headache. Serious side effects are rare but can include serotonin syndrome, a potentially life-threatening condition that occurs when there is too much serotonin in the body. It is important to seek medical attention if symptoms of serotonin syndrome occur, such as rapid heartbeat, high blood pressure, fever, confusion, or seizures.

Prucalopride should be used with caution in patients with a history of seizures, liver disease, or certain heart conditions. It may also interact with other medications, so it is important to inform your healthcare provider about all medications you are taking. Pregnant or breastfeeding women should not use prucalopride unless directed by a healthcare provider.

Prucalopride is not a controlled substance and is available over the counter in some countries. However, it is a prescription medication in the United States and other countries. It is important to follow your healthcare provider's instructions for taking prucalopride and to report any side effects or concerns.